Purpura as an indicator of severity in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: evidence from a 49-case series
J Eur Acad Dermatol Venereol
.
2022 Apr;36(4):e310-e313.
doi: 10.1111/jdv.17838.
Epub 2021 Dec 6.
Authors
S Takei
1
,
N Hama
1
,
Y Mizukawa
2
,
H Takahashi
3
,
F Miyagawa
4
,
H Asada
4
,
R Abe
1
Affiliations
1
Division of Dermatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
2
Department of Dermatology, Kyorin University School of Medicine, Tokyo, Japan.
3
Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.
4
Department of Dermatology, Nara Medical University School of Medicine, Nara, Japan.
PMID:
34839562
DOI:
10.1111/jdv.17838
No abstract available
Publication types
Letter
MeSH terms
Drug Hypersensitivity Syndrome* / diagnosis
Drug Hypersensitivity Syndrome* / etiology
Eosinophilia* / chemically induced
Eosinophilia* / diagnosis
Humans
Purpura*
Grants and funding
H26-nanchi[nan]-ippan-081/Health and Labor Sciences Research Grants from the Ministry of Health, Labor and Welfare of Japan